Diagnoses of drugs primarily affecting the autonomic nervous system
- Level
- Class
- Parent
- 85440000
- Below
- 10
- Links · KBLI
- 9
Definition
UNSPSC 85445600In this classification, this covers the group of activities that yields a diagnosis of drugs primarily affecting the autonomic nervous system. Drugs primarily affecting the autonomic nervous system is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y51. ICD-10 also has The following Drugs primarily affecting the autonomic nervous system children in its four-character category: Y51.0 (Anticholinesterase agents); Y51.1 (Other parasympathomimetics [cholinergics]); Y51.2 (Ganglionic blocking drugs, not elsewhere classified); Y51.3 (Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified); Y51.4 (Predominantly alpha-adrenoreceptor agonists, not elsewhere classified); Y51.5 (Predominantly beta-adrenoreceptor agonists, not elsewhere classified); Y51.6 (Alpha-adrenoreceptor antagonists, not elsewhere classified); Y51.7 (Beta-adrenoreceptor antagonists, not elsewhere classified); Y51.8 (Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified); Y51.9 (Other and unspecified drugs primarily affecting the autonomic nervous system)
Same parent
Under 85440000 · 76Activities that produce or sell this
KBLI · 9Inherited from family 85440000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.